You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our anti-CCR5 (CCR5) Antibodies

Full name:
anti-C-C Chemokine Receptor Type 5 Antibodies (CCR5)
On www.antibodies-online.com are 466 C-C Chemokine Receptor Type 5 (CCR5) Antibodies from 34 different suppliers available. Additionally we are shipping CCR5 Kits (39) and CCR5 Proteins (9) and many more products for this protein. A total of 525 CCR5 products are currently listed.
Synonyms:
AM4-7, CC-CKR-5, CCCKR5, CCR-5, CCR5, CD195, CKR-5, CKR5, CMKBR5, GPCR, IDDM22

All available anti-CCR5 Antibodies

Go to our pre-filtered search.

Top referenced anti-CCR5 Antibodies

  1. Human Polyclonal CCR5 Primary Antibody for WB - ABIN265000 : Doranz, Lu, Rucker, Zhang, Sharron, Cen, Wang, Guo, Du, Accavitti, Doms, Peiper: Two distinct CCR5 domains can mediate coreceptor usage by human immunodeficiency virus type 1. in Journal of virology 1997 (PubMed)
    Show all 8 references for ABIN265000

  2. Human Monoclonal CCR5 Primary Antibody for FACS - ABIN1449163 : Nimura, Zhang, Okuma, Tanaka, Sunakawa, Yamamoto, Tanaka: Cross-linking cell surface chemokine receptors leads to isolation, activation, and differentiation of monocytes into potent dendritic cells. in Experimental biology and medicine (Maywood, N.J.) 2006 (PubMed)
    Show all 5 references for ABIN1449163

  3. Human Monoclonal CCR5 Primary Antibody for FACS - ABIN2853594 : Ichiyama, Yokoyama-Kumakura, Tanaka, Tanaka, Hirose, Bannai, Edamatsu, Yanaka, Niitani, Miyano-Kurosaki, Takaku, Koyanagi, Yamamoto: A duodenally absorbable CXC chemokine receptor 4 antagonist, KRH-1636, exhibits a potent and selective anti-HIV-1 activity. in Proceedings of the National Academy of Sciences of the United States of America 2003 (PubMed)
    Show all 5 references for ABIN2853594

  4. Human Polyclonal CCR5 Primary Antibody for WB - ABIN1881182 : Gérard, Stanich, Oszust, Whittum-Hudson, Carter, Schumacher, Hudson: Functional CCR5 receptor protects patients with arthritis from high synovial burden of infecting Chlamydia trachomatis. in The American journal of the medical sciences 2010 (PubMed)
    Show all 4 references for ABIN1881182

  5. Human Monoclonal CCR5 Primary Antibody for EIA, IF - ABIN180777 : Pollok-Kopp, Schwarze, Baradari, Oppermann: Analysis of ligand-stimulated CC chemokine receptor 5 (CCR5) phosphorylation in intact cells using phosphosite-specific antibodies. in The Journal of biological chemistry 2003 (PubMed)
    Show all 2 references for ABIN180777

  6. Human Polyclonal CCR5 Primary Antibody for EIA, IF - ABIN372756 : Tan, Goedegebuure, Belt, Flaherty, Sankpal, Gillanders, Eberlein, Hsieh, Linehan: Disruption of CCR5-dependent homing of regulatory T cells inhibits tumor growth in a murine model of pancreatic cancer. in Journal of immunology (Baltimore, Md. : 1950) 2009 (PubMed)
    Show all 2 references for ABIN372756

  7. Human Polyclonal CCR5 Primary Antibody for IF (p), IHC (p) - ABIN741375 : Ochoa-Callejero, Pérez-Martínez, Rubio-Mediavilla, Oteo, Martínez, Blanco: Maraviroc, a CCR5 antagonist, prevents development of hepatocellular carcinoma in a mouse model. in PLoS ONE 2013 (PubMed)

  8. Human Polyclonal CCR5 Primary Antibody for IHC, ELISA - ABIN1532235 : Samson, Labbe, Mollereau, Vassart, Parmentier: Molecular cloning and functional expression of a new human CC-chemokine receptor gene. in Biochemistry 1996 (PubMed)

  9. Human Polyclonal CCR5 Primary Antibody for WB - ABIN2779385 : Catano, Agan, Kulkarni, Telles, Marconi, Dolan, Ahuja: Independent effects of genetic variations in mannose-binding lectin influence the course of HIV disease: the advantage of heterozygosity for coding mutations. in The Journal of infectious diseases 2008 (PubMed)

  10. Human Monoclonal CCR5 Primary Antibody for FACS - ABIN119679 : Mueller, Kelly, Strange: Pathways for internalization and recycling of the chemokine receptor CCR5. in Blood 2002 (PubMed)

More Antibodies against CCR5 Interaction Partners

Mouse (Murine) C-C Chemokine Receptor Type 5 (CCR5) interaction partners

  1. In West Nile virus infection of the central nervous system, CCR5 activity is required to limit viral burden in the cerebral cortex.

  2. CCR5 blockade suppresses B16 melanoma growth by inhibiting of IL-6 (show IL6 Antibodies)-Stat3 (show STAT3 Antibodies) signaling pathway via upregulation of SOCS3 (show SOCS3 Antibodies).

  3. Data show that the activation of mammalian target of rapamycin (show FRAP1 Antibodies) complex mTORC1 during encephalomyocarditis virus infection is chemokine (C-C) receptor 5-dependent and promotes the translation of inducible NO synthase (iNOS (show NOS2 Antibodies)) and cyclooxygenase (COX)-2 (show COX2 Antibodies).

  4. CCL5 (show CCL5 Antibodies)-induced endothelial progenitor cell migration was increased by overexpression of CCR5 and that increase was abolished by addition of CCL5 (show CCL5 Antibodies) antibody, suggesting CCL5 (show CCL5 Antibodies)/CCR5 interaction is involved in chemotactic effects of endothelial progenitor cells.

  5. These findings show that migration and activation of immune cells via CCR5 is required for controlling N. caninum parasites during the early phase of the infection.

  6. our results suggest that the detrimental effects of C5a in this model are partly mediated through CCR5 activation downstream of C5aR1 (show C5AR1 Antibodies), which may be evaluated for potential therapeutic exploitation in ALI/ARDS.

  7. CCR5 blockade promotes M2 macrophage activation and improves locomotor activity after spinal cord injury in mice.

  8. CCR5 KO mice show less cartilage degeneration but no change in bone or synovial response to medial meniscal destabilization.

  9. Results indicate that CCR5 deficiency modifies the nigrostriatal dopaminergic neuronal system and bidirectional interaction between neurons and glial cells via CCR5 might be important for dopaminergic neuronal survival

  10. These data bring new insights on the association between viral infections and the chemokine receptor CCR5.

Cow (Bovine) C-C Chemokine Receptor Type 5 (CCR5) interaction partners

  1. Transcript analysis showed that antigen stimulation of WC1(+)gammadelta T cells substantially increased CCR5 expression.

Rhesus Monkey C-C Chemokine Receptor Type 5 (CCR5) interaction partners

  1. CCR5 inhibition may provide a cardioprotective benefit in SIV infection by preventing cardiomyocyte CCR5 signaling.

  2. A vaccine against CCR5 protects a subset of macaques upon intravaginal challenge with simian immunodeficiency virus SIVmac251.

  3. CCR5 downregulation on CD4(+) T cells by TCR activation has no measurable effect on susceptibility to SAIDS.

  4. CD4 and CD8 T cells are more vulnerable to SIV infection, indicating the the ability to express CCR5 may activate and hassten T cell death by SIV infection in vitro.

  5. Results estimate the infectivity of CCR5-tropic simian immunodeficiency virus SIV(mac251) in the gut (show GUSB Antibodies).

  6. observed a significantly higher loss of CCR5(+) CD45RA(-) CD4 (show CD4 Antibodies)(+) T cells in CD8 (show CD8A Antibodies)(+) lymphocyte-depleted macaques than in controls

  7. Virus recovered from CA28 plasma (SHIV(CA28NP)) used both CCR5 and CXCR4 (show CXCR4 Antibodies) for entry, but the virus recovered from lymph node (SHIV(CA28NL)) used CXCR4 (show CXCR4 Antibodies) almost exclusively

Human C-C Chemokine Receptor Type 5 (CCR5) interaction partners

  1. The authors provide the first evidence that shows CCR5 interaction with a dual-tropic HIV-1 Env (show ERVW-1 Antibodies) played a significant role in Env (show ERVW-1 Antibodies)-induced depletion of CD4 (show CD4 Antibodies) T cells.

  2. Data indicate that on addition of the heat-shock proteins GroEL (show GroEL Antibodies)-GroES (show HSPE1 Antibodies) molecular chaperone (show HSP90AA1 Antibodies) system, the folding of the nascent chemokine receptor (show CCR1 Antibodies) type 5 (CCR5) was significantly enhanced.

  3. The results of this study infer CCR5 and CCL5 (show CCL5 Antibodies) participate in the response to tick-borne encephalitis virus, as well as to other neurotropic pathogens.

  4. Enhanced susceptibility of activated endocervical CD4 (show CD4 Antibodies)+ T cells to HIV may be related to increased CCR5 expression by these cell subsets, but did not appear to be due to direct interaction of integrins a4b7 or a4b1 with HIV envelope.

  5. individuals carrying heterozygous or homozygous genotypes (GA+AA) for CCR2 (show CCR2 Antibodies)-64I polymorphisms seem to be at lower risk for cervical lesion [odds ratio (OR) = 0.37, p = 0.0008)]. The same was observed for the A allele (OR = 0.39, p = 0.0002), while no association was detected (p > 0.05) with CCR5-Delta32 polymorphism.

  6. The residues on the N-loop and beta-sheets of MIP-1a (show CCL3 Antibodies) are close to both CCR1 and CCR5, and those in the C-terminal helix region are close to CCR5.

  7. Study provides the evidence that the chemokine receptor CCR5 is highly expressed and associated with poor prognosis in human glioblastoma. Mechanistically, CCL5 (show CCL5 Antibodies)-CCR5 mediates activation of Akt (show AKT1 Antibodies), and subsequently induces proliferation and invasive responses in U87 and U251 cells.

  8. CCR5-Delta32 polymorphism is associated with susceptibility to cancer.

  9. The relationship between CCR5 variation, HIV-1 reservoir size, lymphocyte activation, and CCR (show POR Antibodies)% expression in patients receiving ant-HIV therapy is reported.

  10. the CCR5Delta32 polymorphism does not seem to influence the different clinical manifestations of Chagas disease but there is involvement of the CCR5 59029 A/G polymorphism in susceptibility to the different forms of chronic Chagas disease.

CCR5 Antigen Profile

Antigen Summary

This gene encodes a member of the beta chemokine receptor family, which is predicted to be a seven transmembrane protein similar to G protein-coupled receptors. This protein is expressed by T cells and macrophages, and is known to be an important co-receptor for macrophage-tropic virus, including HIV, to enter host cells. Defective alleles of this gene have been associated with the HIV infection resistance. The ligands of this receptor include monocyte chemoattractant protein 2 (MCP-2), macrophage inflammatory protein 1 alpha (MIP-1 alpha), macrophage inflammatory protein 1 beta (MIP-1 beta) and regulated on activation normal T expressed and secreted protein (RANTES). Expression of this gene was also detected in a promyeloblastic cell line, suggesting that this protein may play a role in granulocyte lineage proliferation and differentiation. This gene is located at the chemokine receptor gene cluster region. Two transcript variants encoding the same protein have been found for this gene.

Alternative names and synonyms associated with CCR5

  • chemokine (C-C motif) receptor 5 (Ccr5) antibody
  • chemokine (C-C motif) receptor 5 (CCR5) antibody
  • chemokine (C-C motif) receptor 5 (gene/pseudogene) (CCR5) antibody
  • AM4-7 antibody
  • CC-CKR-5 antibody
  • CCCKR5 antibody
  • CCR-5 antibody
  • CCR5 antibody
  • CD195 antibody
  • CKR-5 antibody
  • CKR5 antibody
  • CMKBR5 antibody
  • GPCR antibody
  • IDDM22 antibody

Protein level used designations for CCR5

C-C CKR-5 , C-C chemokine receptor type 5 , CC-CKR-5 , CCR-5 , MIP-1 alpha receptor , chemokine (C-C) receptor 5 , C-C chemokine receptor 5 , CC chemokine receptor 5 , chemokine C-C motif receptor 5 , chemokine (C-C motif) receptor 5 , C-C motif chemokine receptor 5 A159A , HIV-1 fusion coreceptor , chemokine receptor CCR5 , chemr13

GENE ID SPECIES
12774 Mus musculus
117029 Rattus norvegicus
100101579 Oryctolagus cuniculus
484789 Canis lupus familiaris
497017 Bos taurus
735311 Macaca mulatta
100126710 Papio anubis
450128 Pan troglodytes
100190809 Pongo abelii
1234 Homo sapiens
Selected quality suppliers for anti-CCR5 (CCR5) Antibodies
Did you look for something else?